ReviewPLoS pathogens2017
New opportunities and challenges to engineer disease resistance in cassava, a staple food of African small-holder farmers.
Review in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 42 citations in OpenAlex.
- Targeting dCas9-SunTag to a Susceptibility Gene Promoter Is Sufficient for CRISPR Interference.Plant direct · 2026Article
- Genome editing in Sub-Saharan Africa: a game-changing strategy for climate change mitigation and sustainable agriculture.GM crops & food · 2024Review
- Trends and practices of weaning in infants across India: A comprehensive review.Journal of family medicine and primary care · 2024Review
- Developing broad-spectrum resistance in cassava against viruses causing the cassava mosaic and the cassava brown streak diseases.Frontiers in plant science · 2023Article
- A comparison of ImageJ and machine learning based image analysis methods to measure cassava bacterial blight disease severity.Plant methods · 2022Article
- Cassava shrunken-2 homolog MeAPL3 determines storage root starch and dry matter content and modulates storage root postharvest physiological deterioration.Plant molecular biology · 2022Article
- Current status and impending progress for cassava structural genomics.Plant molecular biology · 2022Review
- Knowledge, Attitude, and Practice of Weaning among Mothers in Najran Region, Saudi Arabia, 2021.Journal of nutrition and metabolism · 2022Article
- CRISPR for accelerating genetic gains in under-utilized crops of the drylands: Progress and prospects.Frontiers in genetics · 2022Review
- When a knockout is an Achilles' heel: Resistance to one potyvirus species triggers hypersusceptibility to another one in Arabidopsis thaliana.Molecular plant pathology · 2021Article
- Can Cross-Country Genomic Predictions Be a Reasonable Strategy to Support Germplasm Exchange? - A Case Study With Hydrogen Cyanide in Cassava.Frontiers in plant science · 2021Article
- RNA silencing ofBiotechnology reports (Amsterdam, Netherlands) · 2019Article
- Resistance Against Cassava Brown Streak Viruses From Africa in Cassava Germplasm From South America.Frontiers in plant science · 2019Article
- Evaluation of resistance to cassava mosaic disease in selected African cassava cultivars using combined molecular and greenhouse grafting tools.Physiological and molecular plant pathology · 2019Article
- Plant-Pathogen Warfare under Changing Climate Conditions.Current biology : CB · 2018Review
- Trans-species synthetic gene design allows resistance pyramiding and broad-spectrum engineering of virus resistance in plants.Plant biotechnology journal · 2018Article
- Application of CRISPR/Cas9 Genome Editing Technology for the Improvement of Crops Cultivated in Tropical Climates: Recent Progress, Prospects, and Challenges.Frontiers in plant science · 2018Review
- Utilization of engineered resistance to viruses in crops of the developing world, with emphasis on sub-Saharan Africa.Current opinion in virology · 2017Review
- Efficient CRISPR/Cas9 Genome Editing ofFrontiers in plant science · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.